Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of adjuvant BGP-15 plus bisoprolol in inappropriate sinus tachycardia
2020-003005-61Phase 2Completed
- Sponsor
- Sinusventure LLC.
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in inappropriate sinus tachycardia (IST) comparing BGP-15 + bisoprolol with Placebo + bisoprolol (2 arms). Primary endpoint: Proportion of subjects with at least 70% decrease of symptoms. Started Aug 2020; status: completed.
02
Drugs
BGP-15
03
Conditions
inappropriate sinus tachycardia (IST)
Beyond the preview
Go deeper on 2020-003005-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003005-61.